Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	112,343	115,149	103,454	104,854	74,220	55,884
Market Cap Growth	-9.51%	11.30%	-1.33%	41.27%	32.81%	-9.02%
Enterprise Value	101,939	110,388	98,882	94,363	64,254	49,246
Last Close Price	441.67	453.36	402.70	406.89	288.78	219.60
PE Ratio	28.80	29.59	-193.61	29.29	22.53	24.37
Forward PE	23.17	22.61	22.66	24.44	18.83	16.42
PEG Ratio	1.69	0.73	1.21	1.92	0.58	1.62
PS Ratio	9.35	9.59	9.39	10.62	8.31	7.38
PB Ratio	6.00	6.17	6.30	5.96	5.33	5.53
P/TBV Ratio	6.11	6.27	6.33	6.03	5.38	5.65
P/FCF Ratio	35.14	36.05	-130.90	31.42	18.91	23.20
P/OCF Ratio	30.90	31.71	-210.01	29.64	17.97	21.14
EV/Sales Ratio	8.49	9.20	8.97	9.56	7.19	6.50
EV/EBITDA Ratio	20.95	25.18	-3847.55	23.51	14.42	16.94
EV/EBIT Ratio	21.75	26.45	-424.57	24.62	14.92	17.70
EV/FCF Ratio	31.92	34.56	-125.12	28.28	16.37	20.45
Debt / Equity Ratio	0.10	0.10	0.09	0.04	0.06	0.09
Debt / EBITDA Ratio	0.42	0.42	-60.09	0.18	0.18	0.31
Debt / FCF Ratio	0.58	0.58	-1.95	0.22	0.21	0.37
Net Debt / Equity Ratio	-0.25	-0.25	-0.28	-0.60	-0.72	-0.66
Net Debt / EBITDA Ratio	-1.09	-1.09	177.88	-2.61	-2.24	-2.28
Net Debt / FCF Ratio	-1.49	-1.49	5.79	-3.14	-2.54	-2.76
Asset Turnover	0.50	0.50	0.49	0.48	0.57	0.60
Inventory Turnover	1.14	1.14	1.57	2.10	2.66	2.85
Quick Ratio	2.24	2.24	2.17	3.60	4.46	4.04
Current Ratio	2.90	2.90	2.69	3.99	4.83	4.46
Return on Equity (ROE)	22.54%	22.54%	-3.15%	22.99%	27.67%	24.93%
Return on Assets (ROA)	14.75%	14.75%	2.22%	15.49%	21.41%	18.95%
Return on Invested Capital (ROIC)	24.66%	24.66%	4.62%	47.15%	75.33%	63.08%
Return on Capital Employed (ROCE)	20.48%	20.48%	-1.22%	22.16%	32.27%	26.29%
Earnings Yield	3.52%	3.38%	-0.52%	3.41%	4.44%	4.10%
FCF Yield	2.85%	2.77%	-0.76%	3.18%	5.29%	4.31%
Buyback Yield / Dilution	-0.04%	-0.04%	1.00%	-0.54%	0.31%	1.33%
Total Shareholder Return	-0.04%	-0.04%	1.00%	-0.54%	0.31%	1.33%

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q